Med Device Maker Valued At $2.25B In Minority Investment
Private equity firm GTCR said Friday it sold a minority equity stake in medical device manufacturer Resonetics to The Carlyle Group in a deal valuing the portfolio company at $2.25 billion,...To view the full article, register now.
Already a subscriber? Click here to view full article